What are the causes of blackish colored blood in a patient with end-stage renal disease (ESRD) undergoing hemodialysis (HD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blackish Blood During Hemodialysis: Causes and Clinical Approach

Blackish-colored blood during hemodialysis most commonly indicates severe deoxygenation or hemolysis, with mechanical hemolysis being the most critical immediate concern requiring urgent intervention.

Primary Causes

Severe Hemolysis (Most Critical)

  • Mechanical hemolysis from dialysis circuit malfunction is the most dangerous cause and can produce life-threatening systemic complications requiring immediate recognition and treatment 1
  • Mechanical damage to red blood cells can occur from stenosis in dialysis blood lines, kinked tubing, or malfunctioning blood pumps 1
  • Rapid hemolysis releases hemoglobin into plasma, creating a dark, blackish appearance to the blood 1
  • This is a dialysis emergency—if suspected, immediately stop dialysis, clamp lines, and do not return blood to patient 1

Severe Deoxygenation

  • Inadequate oxygenation of blood can cause darkening due to increased deoxygenated hemoglobin concentration
  • May occur with respiratory compromise, severe anemia (common in ESRD), or circulatory issues during dialysis 2
  • Hemodialysis itself induces significant reduction in cerebral blood flow causing hemodynamic instability 3

Uremic Coagulopathy and Blood Stasis

  • ESRD patients have fundamentally altered blood composition with accumulated uremic toxins that affect red blood cell function 3
  • Uremic toxins (indoxyl sulfate, acrolein, urea, p-cresol) cause accelerated eryptosis—premature red blood cell death with membrane changes 4, 3
  • Blood stasis in dialysis lines combined with altered rheology from severe anemia can create darker appearance 3

Secondary Contributing Factors

Iron Overload

  • Chronic IV iron supplementation (common in hemodialysis patients) can lead to hemosiderosis with iron deposits in multiple organs 4
  • Between 1999-2010, hemodialysis patients received increasing IV iron doses (232-281 mg/month), with median ferritin levels rising to 450-650 µg/L 4
  • Iron overload itself doesn't directly cause blackish blood but indicates altered hematologic status 5

Severe Anemia

  • Most ESRD patients have significant anemia which alters blood rheology and appearance 2
  • When hematocrit drops below 25%, blood appears darker and more viscous 3
  • Anemia in ESRD results from decreased erythropoietin production, iron deficiency, and accelerated eryptosis 4

Immediate Clinical Actions

When blackish blood is observed during hemodialysis:

  1. Check for hemolysis immediately 1:

    • Inspect dialysis circuit for mechanical problems (stenosis, kinks, pump malfunction)
    • Draw blood sample to check for free hemoglobin in plasma
    • If hemolysis confirmed: stop dialysis, clamp lines, do NOT return blood to patient
  2. Assess oxygenation status:

    • Check pulse oximetry and respiratory status
    • Evaluate for hemodynamic instability during dialysis 3
  3. Evaluate for blood stasis:

    • Check blood flow rates through dialysis circuit
    • Assess for clotting in lines despite anticoagulation 6, 3
  4. Laboratory evaluation:

    • Complete blood count with hemoglobin/hematocrit
    • Plasma free hemoglobin (if hemolysis suspected)
    • Lactate dehydrogenase (elevated in hemolysis)
    • Ferritin and transferrin saturation (assess iron status) 5

Prevention Strategies

  • Regular inspection and maintenance of dialysis equipment to prevent mechanical hemolysis 1
  • Optimize anticoagulation during dialysis to prevent blood stasis while minimizing bleeding risk 6, 3
  • Maintain adequate hemoglobin levels (though avoid excessive ESA therapy) 2
  • Monitor iron status regularly (ferritin and TSAT every 3 months) to prevent both deficiency and overload 5

Critical Pitfall

Do not dismiss darkened blood as "normal" in dialysis patients—while ESRD patients have multiple hematologic abnormalities, acute changes in blood color during dialysis warrant immediate investigation, particularly to rule out life-threatening hemolysis 1.

References

Research

End-Stage Renal Disease: Medical Management.

American family physician, 2021

Guideline

Pathophysiology of Uremic Coagulopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Iron Supplementation in Hemodialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hematuria and Hematomas in End-Stage Renal Disease (ESRD)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can a patient with End-Stage Renal Disease (ESRD) on hemodialysis undergo an Esophagogastroduodenoscopy (EGD)?
Should weekly labs be continued or reduced to once a month for a patient with stable end-stage renal disease on hemodialysis?
What is erythema infectiosum (Fifth disease)?
What home health interventions are appropriate for a 74-year-old female with hypertension, hyperlipidemia, end-stage renal disease (ESRD) on dialysis, anxiety disorder, insomnia, gastroesophageal reflux disease (GERD), generalized muscle weakness, and urinary incontinence, taking medications including quetiapine (Seroquel) 25mg, alprazolam 0.5mg, cetirizine (Zyrtec) 10mg, amlodipine 10mg, esomeprazole (Nexium) 40mg, labetalol 200mg, losartan 100mg, furosemide 40mg, zolpidem 12.5mg, sevelamer 800mg, and albuterol sulfate, with normal vitals and hypotension, and an allergy to codeine?
What is the best treatment approach for a 65-year-old male with End-Stage Renal Disease (ESRD) on dialysis and a Gleason score 8 prostate cancer with no evidence of metastasis?
What is the first line of management for an adult patient with newly diagnosed hypertension and no significant comorbidities?
What is the best course of treatment for a patient with recurrent central neurocytoma (CN) and residual tumor after surgery?
Can clopidogrel (Plavix) and aspirin be given to a patient with a hemorrhagic stroke?
What is the treatment approach for a patient presenting with symptoms of labyrinthitis versus vestibular neuronitis, including vertigo, nausea, and hearing loss?
What are the medical management options for a patient with postural hypotension, considering non-pharmacological and pharmacological interventions?
What is the main difference between single incision (SI) and multiple incision (MI) laparoscopic cholecystectomy (lap cholecystectomy)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.